To Compare the PK, PD, Safety & Immunogenicity of ADL-018 in Healthy Subjects

NCT05413161 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
306
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Kashiv BioSciences, LLC